Rituximab

Rituximab

Rituximab
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells. Rituximab is used in the treatment of many lymphomas, leukemias, transplant rejection and some autoimmune disorders.

Rituximab - List of case studies

Drugs

Riluzole Riopan Risedronate Rituxan Rituximab Rofeoxib Roferon A 3000000 U Rosoglitazone Rx - ...

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)_2

-        Rituximab a monoclonal anti-CD20 antibody against B-cells maybe an ... Intravenous immunoglobulin (IVIG) ,cyclosporine, Rituximab . Treatments : hypocholesterolemizing therapy, intravenous ...

Thrombotic thrombocytopenic purpura (TTP) secondary to Systemic Lupus Erythematosus (SLE)

He was treated again with steroids and plasma therapy. Rituximab was added with eventual remission. A renal biopsy was obtained ... carried out), while it was positive after 3 dosages of Rituximab (in total 4 doses were administered). If a further TTP relapse would ...

ABO-incompatible (ABOI) renal transplantation

using antigen-specific immunoadsorption (IA) and rituximab.   questions:  ... technique using antigen-specific immunoadsorption (IA) and rituximab.   ... using antigen-specific immunoadsorption (IA) and rituximab , was published by the Stockholm group in 2005. In summary about 60 ...

JustAnswer.com